| Serial Number | 79445801 |
| Word Mark | VALALTO LIFE BEYOND CARE |
| Filing Date | Wednesday, January 7, 2026 |
| Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
| Status Date | Thursday, June 25, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Retail store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; wholesale store services featuring pharmaceutical, veterinary and sanitary preparations and medical supplies; marketing services; advertising services |
| Goods and Services | Arranging and conducting of in-person educational forums in the field of pharmaceuticals; Educational services in the nature of pharmaceuticals schools; providing information in the field of education; providing online electronic publications, not downloadable, namely, brochures in the field of pharmaceuticals; arranging and conducting of conferences in the field of pharmaceuticals; arranging and conducting of congresses in the field of pharmaceuticals; arranging and conducting of colloquiums in the field of pharmaceuticals; arranging and conducting of seminars in the field of pharmaceuticals; arranging and conducting of symposiums in the field of pharmaceuticals |
| Goods and Services | Dietetic foods adapted for medical purposes; teeth filling material; herbicides; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; pharmaceutical preparations for the treatment of neuroendocrine disorders; fungicides; food for babies; dietetic substances in the nature of dietetic foods adapted for medical use; disinfectants; nutritional supplements for medical purposes; homogenized food adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; Food supplements, namely, anti-oxidants; dietetic beverages adapted for medical purposes; vitamin supplement patches; dietary fibre supplements; glycerine for medical purposes; immunostimulants; protein dietary supplements; mineral dietary supplements; dietary supplements for human beings; medicated lotions for pharmaceutical purposes; narcotics being pharmaceuticals for the treatment of pain; opiates being pharmaceuticals for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of cancer; Pharmaceutical preparations in the form of pastilles for the treatment of pain; Pharmaceutical preparations in the form of pastilles for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; Pharmaceutical preparations in the form of pastilles for the treatment of neuroendocrine disorders; chemical preparations for pharmaceutical purposes for the treatment of cancer; chemical preparations for pharmaceutical purposes for the treatment of pain; chemical preparations for pharmaceutical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for pharmaceutical purposes for the treatment of neuroendocrine disorders; chemical preparations for medical purposes for the treatment of cancer; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemical preparations for medical purposes for the treatment of pain; chemical preparations for medical purposes for the treatment of neuroendocrine disorders; Aloe vera preparations for pharmaceutical purposes; phytotherapy preparations for medical purposes; nutraceutical preparations for therapeutic or medical purposes for the treatment of cancer-related conditions; vitamin preparations; chemico-pharmaceutical preparations for the treatment of cancer; chemico-pharmaceutical preparations for the treatment of pain; chemico-pharmaceutical preparations for the treatment of rare diseases, namely, for Sarcomas and Systemic Mastocytosis; chemico-pharmaceutical preparations for the treatment of neuroendocrine disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 12, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 12, 2026 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 12, 2026 |
| Primary Code | 041 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | MEDIOLANUM FARMACEUTICI S.p.A. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | IT |
| Event Date | Event Description |
| Thursday, March 12, 2026 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, March 16, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 16, 2026 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, March 25, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, April 1, 2026 | NON-FINAL ACTION WRITTEN |
| Thursday, April 2, 2026 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, May 21, 2026 | REFUSAL PROCESSED BY MPU |
| Thursday, May 21, 2026 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Thursday, June 4, 2026 | REFUSAL PROCESSED BY IB |
| Thursday, June 25, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, June 25, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 25, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |